Uterine Drug-Delivery Systems

Sustained and controlled release drug delivery systems (DDSs) are widely investigated for disease diagnosis and treatment. Advanced DDS provides critical advantages over traditional DDSs, particularly by bypassing systemic circulation and first-pass metabolism. This enhances the drug payload at the target site and reduces systemic side effects. Uterine drug delivery is already widely used with contraceptive intrauterine devices, but further explorations to treat uterine fibroids, uterine cancer, and endometriosis are still being developed. Advances in these systems will provide critical clinical enhancements over the current treatment options. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

Fanse S, Bao Q, Burgess DJ. Long-acting intrauterine systems: recent advances, current challenges, and future opportunities. Adv Drug Deliv Rev. 2022;191:114581. https://doi.org/10.1016/j.addr.2022.114581. Rowlands S, Oloto E, Horwell DH. Intrauterine devices and risk of uterine perforation: current perspectives. Open Access J Contracept. 2016;7:19–32. https://doi.org/10.2147/OAJC.S85546. Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig. 2006;13(7):467–76. Elizur S, Mostafa J, Berkowitz E, Orvieto R. Endometriosis and infertility: pathophysiology, treatment strategies, and reproductive outcomes. Arch Gynecol Obstet. 2025;312(4):1037–48. https://doi.org/10.1007/s00404-025-08124-1. Sridhar S, Gallant T, Brunn E. Overview of pathogenesis, symptoms, diagnosis, management, and prognosis of endometriosis and its role in infertility. J Gynecol Surg. 2022;38(1):3–6. https://doi.org/10.1089/gyn.2021.0160. França PRC, Lontra ACP, Fernandes PD. Endometriosis: a disease with few direct treatment options. Molecules. 2022;27(13). https://doi.org/10.3390/molecules27134034. Toma L, Socolov D, Matei D, Anton S, Balan R, Anton E, et al. Intrauterine adhesions and Asherman syndrome: a retrospective dive into predictive risk factors, diagnosis, and surgical perspectives. Diagnostics. 2025;15(8). https://doi.org/10.3390/diagnostics15080955. Sun W, Xu W, Xiao M, Zhang X, Chen J, Zhang J, et al. Enhancing exosome stability and delivery with natural polymers to prevent intrauterine adhesions and promote endometrial regeneration: a review. J Nanobiotechnol. 2025;23(1):529. https://doi.org/10.1186/s12951-025-03603-8. Düz SA, Mumcu A, Doğan B, Sarıdoğan E, Tuncay G, Onat T, et al. Metabolomics approach using HR-MAS NMR spectroscopy for the assessment of metabolic profiles of uterine fibroids. Anal Biochem. 2025;704:115885. https://doi.org/10.1016/j.ab.2025.115885. Bofill Rodriguez M, Lethaby A, Grigore M, Brown J, Hickey M, Farquhar C. Endometrial resection and ablation techniques for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;1(1):CD001501. https://doi.org/10.1002/14651858.CD001501.pub5. Zhang Q, Liang X, Chen Z. An updated review of thermal ablation technology for uterine fibroids and adenomyosis: focusing on protecting fertility. Int J Womens Health. 2024;16:1551–63. https://doi.org/10.2147/ijwh.S473005. Vrede SW, Kasius J, Bulten J, Teerenstra S, Huvila J, Colas E, et al. Relevance of molecular profiling in patients with low-grade endometrial cancer. JAMA Netw Open. 2022;5(12):e2247372. https://doi.org/10.1001/jamanetworkopen.2022.47372. Khouri OR, Frey MK, Musa F, Muggia F, Lee J, Boyd L, et al. Neoadjuvant chemotherapy in patients with advanced endometrial cancer. Cancer Chemother Pharmacol. 2019;84(2):281–5. https://doi.org/10.1007/s00280-019-03838-x. Matei D, Filiaci V, Randall ME, Mutch D, Steinhoff MM, DiSilvestro PA, et al. Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer. N Engl J Med. 2019;380(24):2317–26. https://doi.org/10.1056/NEJMoa1813181. Nomura H, Aoki D, Michimae H, Mizuno M, Nakai H, Arai M, et al. Effect of taxane plus platinum regimens vs doxorubicin plus cisplatin as adjuvant chemotherapy for endometrial cancer at a high risk of progression: a randomized clinical trial. JAMA Oncol. 2019;5(6):833–40. https://doi.org/10.1001/jamaoncol.2019.0001. Bestvina CM, Fleming GF. Chemotherapy for endometrial cancer in adjuvant and advanced disease settings. Oncologist. 2016;21(10):1250–9. https://doi.org/10.1634/theoncologist.2016-0062. Berezowitz JD, Givens BE. Nanocarrier drug delivery systems for gynecological cancer therapeutics. J Control Release. 2025;385:114028. https://doi.org/10.1016/j.jconrel.2025.114028. Wang Y, Levate G, Rae MT, Duncan WC, Siemienowicz KJ. An ovine model shows that subcutaneous adipose tissue fibrosis occurs early in polycystic ovary syndrome (PCOS). J Mol Endocrinol. 2025;75(4). https://doi.org/10.1530/jme-25-0106. McCracken JM, Calderon GA, Robinson AJ, Sullivan CN, Cosgriff-Hernandez E, Hakim JCE. Animal models and alternatives in vaginal research: a comparative review. Reprod Sci. 2021;28(6):1759–73. https://doi.org/10.1007/s43032-021-00529-y. Dick I, Scott R. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol. 1992;44(8):640–5. https://doi.org/10.1111/j.2042-7158.1992.tb05485.x. Han I, Bohrer L, Gibson-Corley K, Wiley L, Shrestha A, Harman B, et al. Biocompatibility of human induced pluripotent stem cell-derived retinal progenitor cell grafts in immunocompromised rats. Cell Transplant. 2022;31. https://doi.org/10.1177/09636897221104451. Liu P, Meng J, Xiong Y, Wu Y, Xiao Y, Gao S. Contraception with levonorgestrel-releasing intrauterine system versus copper intrauterine device: a meta-analysis of randomized controlled trials. EClinicalMedicine. 2024;78:102926. https://doi.org/10.1016/j.eclinm.2024.102926. Xu XX, Nie FL, Wang YB, Zhang JX, Zheng W, Li L, et al. Effective inhibition of the early copper ion burst release with ultra-fine grained copper and single crystal copper for intrauterine device application. Acta Biomater. 2012;8(2):886–96. https://doi.org/10.1016/j.actbio.2011.10.018. Alvarez F, Schilardi PL, de Mele MFL. Reduction of the “burst release” of copper ions from copper-based intrauterine devices by organic inhibitors. Contraception. 2012;85(1):91–8. Yang L, Bao G, Yao C, Diao T, Su Z, Liu T, et al. Mitigating adverse effects of Cu-containing intrauterine devices using a highly biocompatible Cu5Fe alloy. Acta Biomater. 2024;189:651–67. https://doi.org/10.1016/j.actbio.2024.09.022. Fan Q, Bao G, Ge D, Wang K, Sun M, Liu T, et al. Effective easing of the side effects of copper intrauterine devices using ultra-fine-grained Cu-0.4 Mg alloy. Acta Biomater. 2021;128:523–39. Wang K, Bao G, Fan Q, Zhu L, Yang L, Liu T, et al. Feasibility evaluation of a Cu-38 Zn alloy for intrauterine devices: in vitro and in vivo studies. Acta Biomater. 2022;138:561–75. https://doi.org/10.1016/j.actbio.2021.11.006. Turok DK, Nelson AL, Dart C, Schreiber CA, Peters K, Schreifels MJ, et al. Efficacy, safety, and tolerability of a new low-dose copper and nitinol intrauterine device: phase 2 data to 36 months. Obstet Gynecol. 2020;135(4):840–7. https://doi.org/10.1097/AOG.0000000000003756. Barton BE, Erickson JA, Allred SI, Jeffries JM, Stephens KK, Hunter MI, et al. Reversible female contraceptives: historical, current, and future perspectivesdagger. Biol Reprod. 2024;110(1):14–32. https://doi.org/10.1093/biolre/ioad154. Baram I, Weinstein A, Trussell J. The IUB, a newly invented IUD: a brief report. Contraception. 2014;89(2):139–41. https://doi.org/10.1016/j.contraception.2013.10.017. Homminga I, Ter Meer AF, Groen H, Cantineau AEP, Hoek A. Thin endometrial lining: is it more prevalent in patients utilizing preimplantation genetic testing for monogenic disease (PGT-M) and related to prior hormonal contraceptive use? Hum Reprod. 2023;38(2):237–46. https://doi.org/10.1093/humrep/deac258. Yu Y, Zhou Z, Wang L, Liu J. Effect of mirena intrauterine device on endometrial thickness, quality of life score, and curative effect in patients with perimenopausal abnormal uterine bleeding. Comput Math Methods Med. 2022;2022(1):5648918. https://doi.org/10.1155/2022/5648918. Bao Q, Zou Y, Wang Y, Kozak D, Choi S, Burgess DJ. Drug release testing of long-acting intrauterine systems. J Control Release. 2019;316:349–58. https://doi.org/10.1016/j.jconrel.2019.11.015. Bao Q, Fanse S, Lu XJ, Burgess DJ. Impact of drug loading on release from levonorgestrel intrauterine systems. Int J Pharm. 2023;631:122532. https://doi.org/10.1016/j.ijpharm.2022.122532. Fanse S, Bao Q, Zou Y, Wang Y, Burgess DJ. Tailoring drug release from long-acting contraceptive levonorgestrel intrauterine systems. J Control Release. 2024;370:124–39. https://doi.org/10.1016/j.jconrel.2024.04.027. Kerns JL, Keder LM, Cwiak CA, Westhoff CL, Creinin MD. Hormone-related side effects in new users of a levonorgestrel 52-mg intrauterine device. Am J Obstet Gynecol. 2024;231(6):628 e1–e10. https://doi.org/10.1016/j.ajog.2024.06.049. Ewies AA. Levonorgestrel-releasing intrauterine system–the discontinuing story. Gynecol Endocrinol. 2009;25(10):668–73. https://doi.org/10.1080/09513590903159656. Borovac T, Pelage JP, Kasselouri A, Prognon P, Guiffant G, Laurent A. Release of ibuprofen from beads for embolization: in vitro and in vivo studies. J Control Release. 2006;115(3):266–74. https://doi.org/10.1016/j.jconrel.2006.08.008. Zhou C, Cui D, Zhang Y, Yuan H, Fan T. Preparation and characterization of ketoprofen-loaded microspheres for embolization. J Mater Sci Mater Med. 2012;23(2):409–18. https://doi.org/10.1007/s10856-011-4492-3. Wassef M, Pelage JP, Velzenberger E, Namur J, Schwartz-Cornil I, Taylor RR, et al. Anti-inflammatory effect of ibuprofen-loaded embolization beads in sheep uterus. J Biomed Mater Res B Appl Biomater. 2008;86(1):63–73. https://doi.org/10.1002/jbm.b.30988. Namur J, Wassef M, Pelage JP, Lewis A, Manfait M, Laurent A. Infrared microspectroscopy analysis of ibuprofen release from drug eluting beads in uterine tissue. J Control Release. 2009;135(3):198–202. https://doi.org/10.1016/j.jconrel.2008.12.017. Verret V, Bevilacqua C, Schwartz-Cornil I, Pelage JP, Wassef M, Namur J, et al. IL6 and TNF expression in vessels and surrounding tissues after embolization with ibuprofen-loaded beads confirms diffusion of ibuprofen. Eur J Pharm Sci. 2011;42(5):489–95. https://doi.org/10.1016/j.ejps.2011.02.001. Bedouet L, Moine L, Servais E, Beilvert A, Labarre D, Laurent A. Tunable delivery of niflumic acid from resorbable embolization microspheres for uterine fibroid embolization. Int J Pharm. 2016;511(1):253–61. https://doi.org/10.1016/j.ijpharm.2016.06.128. Spadea A, Rios de la Rosa JM, Tirella A, Ashford MB, Williams KJ, Stratford IJ, et al. Evaluating the efficiency of hyaluronic acid for tumor targeting via CD44. Mol Pharm. 2019;16(6):2481–93. https://doi.org/10.1021/acs.molpharmaceut.9b00083. Chen WH, Luo GF, Qiu WX, Lei Q, Hong S, Wang SB, et al. Programmed nanococktail for intracellular cascade reaction regulating self-synergistic tumor targeting therapy. Small. 2016;12(6):733–44. https://doi.org/10.1002/smll.201503280. Schatz-Siemers N, Chen YT, Chen Z, Wang D, Ellenson LH, Du YN. Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in endometrial cancer is associated with adverse histologic parameters and tumor progression. Appl Immunohistochem Mol Morphol. 2020;28(6):453–9. https://doi.org/10.1097/PAI.0000000000000763. Hernandez JE, Gonzalez-Montiel A, Allos-Villalva JCC, Cantu D, Barquet S, Olivares-Mundo A, et al. Prognostic molecular biomarkers in endometrial cancer: a review. J Cancer Res Ther (Manch). 2019;7(3):17–28. https://doi.org/10.14312/2052-4994.2019-3. Zhao J, Liu T, Yu G, Wang J. Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer. Tumour Biol. 2015;36(2):1299–306. https://doi.org/10.1007/s13277-014-2761-8. Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Fambrini M, et al. Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer. Oncol Rep. 2019;41(3):1560–74. https://doi.org/10.3892/or.2018.6939. Kong C, Zhu Z, Li Y, Xue P, Chen L. Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway. Clin Transl Oncol. 2021;23(7):1334–41. https://doi.org/10.1007/s12094-020-02520-6. Wang J, Zhang L, Jiang W, Zhang R, Zhang B, Silayiding A, et al. MicroRNA-135a promotes proliferation, migration, invasion and induces chemoresistance of endometrial cancer cells. Eur J Obstet Gynecol Reprod Biol X. 2020;5:100103. https://doi.org/10.1016/j.eurox.2019.100103. Thiel KW, Devor EJ, Filiaci VL, Mutch D, Moxley K, Alvarez Secord A, et al. TP53 sequencing and p53 immunohistochemistry predict outcomes when bevacizumab is added to frontline chemotherapy in endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol. 2022;40(28):3289–300. https://doi.org/10.1200/JCO.21.02506. Ebeid K, Meng X, Thiel KW, Do AV, Geary SM, Morris AS, et al. Synthetically lethal nanoparticles for treatment of endometrial cancer. Nat Nanotechnol. 2018;13(1):72–81. https://doi.org/10.1038/s41565-017-0009-7. Wiwatchaitawee K, Mekkawy AI, Quarterman JC, Naguib YW, Ebeid K, Geary SM, et al. The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles. Drug Deliv Transl Res. 2022;12(7):1684–96. https://doi.org/10.1007/s13346-021-01065-7. Melendez B, Shah S, Jiang Y, Dottino J, Watson E, Pearce H, et al. Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications. J Control Release. 2021;339:521–30. https://doi.org/10.1016/j.jconrel.2021.10.008. Varan C, Aksut D, Sen M, Bilensoy E. Design and characterization of carboplatin and paclitaxel loaded PCL filaments for 3D printed controlled release intrauterine implants. Pharmaceutics. 2023;15(4):1154. https://doi.org/10.3390/pharmaceutics15041154. Mei L, Bao J, Tang L, Zhang C, Wang H, Sun L, et al. A novel mifepristone-loaded implant for long-term treatment of endometriosis: in vitro and in vivo studies. Eur J Pharm Sci. 2010;39(5):421–7. https://doi.org/10.1016/j.ejps.2010.01.012. Yao Q, Zheng YW, Lan QH, Wang LF, Huang ZW, Chen R, et al. Aloe/poloxamer hydrogel as an injectable beta-estradiol delivery scaffold with multi-therapeutic effects to promote endometrial regeneration for intrauterine adhesion treatment. Eur J Pharm Sci. 2020;148:105316. https://doi.org/10.1016/j.ejps.2020.105316. MacCarthy-Morrogh L, Martin P. The hallmarks of cancer are also the hallmarks of wound healing. Sci Signal. 2020;13(648). https://doi.org/10.1126/scisignal.aay8690. Toczek J, Sadlocha M, Major K, Stojko R. Benefit of silver and gold nanoparticles in wound healing process after endometrial cancer protocol. Biomedicine. 2022;10(3). https://doi.org/10.3390/biomedicines10030679. Li S, Li Y, Yu F, Li N, Liu C, Mao J, et al. Human endometrium-derived adventitial cell spheroid-loaded antimicrobial microneedles for uterine regeneration. Small. 2022;18(31):e2201225. https://doi.org/10.1002/smll.202201225. Chitcholtan K, Asselin E, Parent S, Sykes PH, Evans JJ. Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer. Exp Cell Res. 2013;319(1):75–87. https://doi.org/10.1016/j.yexcr.2012.09.012. Ahn J, Yoon MJ, Hong SH, Cha H, Lee D, Koo HS, et al. Three-dimensional microengineered vascularised endometrium-on-a-chip. Hum Reprod. 2021;36(10):2720–31. https://doi.org/10.1093/humrep/deab186. Jamaluddin MFB, Ghosh A, Ingle A, Mohammed R, Ali A, Bahrami M, et al. Bovine and human endometrium-derived hydrogels support organoid culture from healthy and cancerous tissues. Proc Natl Acad Sci USA. 2022;119(44):e2208040119. https://doi.org/10.1073/pnas.2208040119. Huang Y, Feng Q, Jiang H, Zhou W, Chen J, Gao J, et al. Mimicking the endometrial cancer tumor microenvironment to reprogram tumor-associated macrophages in disintegrable supramolecular gelatin hydrogel. Int J Nanomedicine. 2020;15:4625–37. https://doi.org/10.2147/IJN.S252074. Salamonsen LA, Hutchison JC, Gargett CE. Cyclical endometrial repair and regeneration. Development. 2021;148(17). https://doi.org/10.1242/dev.199577. Santamaria X, Isaacson K, Simón C. Asherman’s syndrome: it may not be all our fault. Hum Reprod. 2018;33(8):1374–80. Ghahremani-Nasab M, Babaie S, Bazdar S, Paiva-Santos AC, Del Bakhshayesh MR, Akbari-Gharalari N, et al. Infertility treatment using polysaccharides-based hydrogels: new strategies in tissue engineering and regenerative medicine. J Nanobiotechnol. 2025;23(1):162. https://doi.org/10.1186/s12951-025-03267-4. Wang P-H, Yang S-T, Chang W-H, Liu C-H, Liu H-H, Lee W-L. Intrauterine adhesion. Taiwan J Obstet Gynecol. 2024;63(3):312–9. https://doi.org/10.1016/j.tjog.2024.02.004. Lv H, Xu R, Xie X, Liang Q, Yuan W, Xia Y, et al. Injectable, degradable, and mechanically adaptive hydrogel induced by L-serine and allyl-functionalized chitosan with platelet-rich plasma for treating intrauterine adhesions. Acta Biomater. 2024;184:144–55. https://doi.org/10.1016/j.actbio.2024.06.043. He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425. https://doi.org/10.1038/s41392-021-00828-5. Xie X, Ao X, Xu R, Lv H, Tan S, Wu J, et al. Injectable, stable, and biodegradable hydrogel with platelet-rich plasma induced by l-serine and sodium alginate for effective treatment of intrauterine adhesions. Int J Biol Macromol. 2024;270:132363. https://doi.org/10.1016/j.ijbiomac.2024.132363. Zheng X, Huang R, Yin L, Yao M, Chu J, Yang F, et al. Injectable antioxidant hyaluronan/chitosan hydrogel as a platelet-rich plasma and stem cell carrier to promote endometrial regeneration and fertility restoration. Acta Biomater. 2025;195:201–15. https://doi.org/10.1016/j.actbio.2025.01.062. Avilla-Royo E, Vonzun L, Seehusen F, Vallmajo-Martin Q, Famos F, Moser L, et al. Engineered platelet-derived growth factor-releasing hydrogels promote fetal membrane healing in vivo. Adv Funct Mater. 2023;33(9):2208910. Lu P, Ruan D, Huang M, Tian M, Zhu K, Gan Z, et al. Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. Signal Transduct Target Ther. 2024;9(1):166. https://doi.org/10.1038/s41392-024-01852-x. Guan X, Avci-Adali M, Alarcin E, Cheng H, Kashaf SS, Li Y, et al. Development of hydrogels for regenerative engineering. Biotechnol J. 2017;12(5):1600394. https://doi.org/10.1002/biot.201600394. Wu F, Lei N, Yang S, Zhou J, Chen M, Chen C, et al. Treatment strategies for intrauterine adhesion: focus on the exosomes and hydrogels. Front Bioeng Biotechnol. 2023;11:1264006. https://doi.org/10.3389/fbioe.2023.1264006. Xiao Y, Gu Y, Qin L, Chen L, Chen X, Cui W, et al. Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy. Colloids Surf B Biointerfaces. 2021;200:111581. https://doi.org/10.1016/j.colsurfb.2021.111581. Wang J, Qin W, Zhong Y, Hu H, Yang J, Huang H, Huang N, Liu S, Li J, Zheng L, Qin A, Lu Z. Injectable collagen hydrogel combines human umbilical cord mesenchymal stem cells to promote endometrial regeneration in rats with thin endometrium. Int J Biol Macromol. 2024;254:127591. https://doi.org/10.1016/j.ijbiomac.2023.127591. Wei S, Li Z, Xia H, Wang Z, Deng J, Li L, Huang R, Ye T, Huang Y, Yang Y. An endometrial biomimetic extracellular matrix (ECM) for enhanced endometrial regeneration using hyaluronic acid hydrogel containing recombinant human type III collagen. Int J Biol Macromol 2024;268:131723. https://doi.org/10.1016/j.ijbiomac.2024.131723. Lin Y, Dong S, Ye X, Liu J, Li J, Zhang Y, et al. Synergistic regenerative therapy of thin endometrium by human placenta-derived mesenchymal stem cells encapsulated within hyaluronic acid hydrogels. Stem Cell Res Ther. 2022;13(1):66. https://doi.org/10.1186/s13287-022-02717-2. Xin L, Wei C, Tong X, Dai Y, Huang D, Chen J, et al. In situ delivery of apoptotic bodies derived from mesenchymal stem cells via a hyaluronic acid hydrogel: a therapy for intrauterine adhesions. Bioact Mater. 2022;12:107–19. https://doi.org/10.1016/j.bioactmat.2021.10.025. Xu X, Lai Y, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39(1):BSR20180992. https://doi.org/10.1042/BSR20180992. Ryoo HD, Gorenc T, Steller H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell. 2004;7(4):491–501. https://doi.org/10.1016/j.devcel.2004.08.019. Gorgieva S, Kokol V. Collagen-vs. gelatine-based biomaterials and their biocompatibility: review and perspectives. Biomaterials applications for nanomedicine. 2011;2(2011):17–52. https://doi.org/10.5772/1957. Afewerki S, Sheikhi A, Kannan S, Ahadian S, Khademhosseini A. Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: towards natural therapeutics. Bioeng Transl Med. 2019;4(1):96–115. https://doi.org/10.1002/btm2.10124. Zambuto SG, Clancy KB, Harley BA. A gelatin hydrogel to study endometrial angiogenesis and trophoblast invasion. Interface Focus. 2019;9(5):20190016. Pence JC, Clancy KBH, Harley BAC. Proangiogenic activity of endometrial epithelial and stromal cells in response to estradiol in gelatin hydrogels. Adv Biosyst. 2017;1(9):1700056. https://doi.org/10.1002/adbi.201700056. Shuai Q, Liang Y, Xu X, Halbiyat Z, Wang X, Cheng J, et al. Sodium alginate hydrogel integrated with type III collagen and mesenchymal stem cell to promote endometrium regeneration and fertility restoration. Int J Biol Macromol. 2023;253(Pt 6):127314. https://doi.org/10.1016/j.ijbiomac.2023.127314. Fang Z, Lu C, Du W, Wang X, Yang H, Shi M, et al. Injectable self-assembled dual-crosslinked alginate/recombinant collagen-based hydrogel for endometrium regeneration. Int J Biol Macromol. 2023;236:123943. https://doi.org/10.1016/j.ijbiomac.2023.123943. Yadav M, Kaushik B, Rao GK, Srivastava CM, Vaya D. Advances and challenges in the use of chitosan and its derivatives in biomedical fields: a review. Carbohydr Polym Technol Appl. 2023;5:100323. https://doi.org/10.1016/j.carpta.2023.100323. Wenbo Q, Lijian X, Shuangdan Z, Jiahua Z, Yanpeng T, Xuejun Q, et al. Controlled releasing of SDF-1alpha in chitosan-heparin hydrogel for endometrium injury healing in rat model. Int J Biol Macromol. 2020;143:163–72. https://doi.org/10.1016/j.ijbiomac.2019.11.184. Lopez-Martinez S, Rodriguez-Eguren A, de Miguel-Gomez L, Frances-Herrero E, Faus A, Diaz A, et al. Bioengineered endometrial hydrogels with growth factors promote tissue regeneration and restore fertility in murine models. Acta Biomater. 2021;135:113–25. https://doi.org/10.1016/j.actbio.2021.08.025. Li X, Li P, Wang C, Shang T, Han H, Tong Y, et al. A thermo-sensitive and injectable hydrogel derived from a decellularized amniotic membrane to prevent intrauterine adhesion by accelerating endometrium regeneration. Biomater Sci. 2022;10(9):2275–86. https://doi.org/10.1039/d1bm01791h. Thang NH, Chien TB, Cuong DX. Polymer-based hydrogels applied in drug delivery: an overview. Gels. 2023;9(7):523. https://doi.org/10.3390/gels9070523. Reddy MSB, Ponnamma D, Choudhary R, Sadasivuni KK. A comparative review of natural and synthetic biopolymer composite scaffolds. Polymers (Basel). 2021;13(7):1105. https://doi.org/10.3390/polym13071105. Sionkowska A. Current research on the blends of natural and synthetic polymers as new biomaterials: review. Prog Polym Sci. 2011;36(9):1254–76. https://doi.org/10.1016/j.progpolymsci.2011.05.003. Christen MO, Vercesi F. Polycaprolactone: how a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics. Clin Cosmet Investig Dermatol. 2020;13:31–48. https://doi.org/10.2147/CCID.S229054. Wang X, Yang CR, Zhao ZD, Liu DG, Li CZ. Gelatin/polycaprolactone membranes promote endometrial regeneration and restore fertility. Gynecol Endocrinol. 2024;40(1):2442728. https://doi.org/10.1080/09513590.2024.2442728. Hanuman S, Nune M. Design and characterization of maltose-conjugated polycaprolactone nanofibrous scaffolds for uterine tissue engineering. Regen Eng Transl Med. 2022;8:334–44. Zarrintaj P, Ramsey JD, Samadi A, Atoufi Z, Yazdi MK, Ganjali MR, et al. Poloxamer: a versatile tri-block copolymer for biomedical applications. Acta Biomater. 2020;110:37–67. https://doi.org/10.1016/j.actbio.2020.04.028. Brambilla E, Locarno S, Gallo S, Orsini F, Pini C, Farronato M, et al. Poloxamer-based hydrogel as drug delivery system: how polymeric excipients influence the chemical-physical properties. Polymers (Basel). 2022;14(17):3624. https://doi.org/10.3390/polym14173624. Khaliq NU, Lee J, Kim S, Sung D, Kim H. Pluronic F-68 and F-127 based nanomedicines for advancing combination cancer therapy. Pharmaceutics. 2023;15(8):2102. https://doi.org/10.3390/pharmaceutics15082102. Xu HL, Xu J, Zhang SS, Zhu QY, Jin BH, ZhuGe DL, et al. Temperature-sensitive heparin-modified poloxamer hydrogel with affinity to KGF facilitate the morphologic and functional recovery of the injured rat uterus. Drug Deliv. 2017;24(1):867–81. https://doi.org/10.1080/10717544.2017.1333173. Zhou S, Lei Y, Wang P, Chen J, Zeng L, Qu T, et al. Human umbilical cord mesenchymal stem cells encapsulated with Pluronic F-127 enhance the regeneration and angiogenesis of thin endometrium in rat via local IL-1beta stimulation. Stem Cells Int. 2022;2022(1):7819234. https://doi.org/10.1155/2022/7819234. Wu Y, Gu S, Cobb JM, Dunn GH, Muth TA, Simchick CJ, et al. E2-loaded microcapsules and bone marrow-derived mesenchymal stem cells with injectable scaffolds for endometrial regeneration application. Tissue Eng Part A. 2024;30(3–4):115–30. https://doi.org/10.1089/ten.TEA.2023.0238. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2026 The Author(s), under exclusive license to Springer Nature Switzerland AG About this chapter Cite this chapter Mehanna, L.E., Rowlands, C.E., Givens, B.E. (2026). Uterine Drug-Delivery Systems. In: Zambuto, S.G., Oyen, M.L. (eds) Biomaterials for Women’s Health Engineering. Springer, Cham. https://doi.org/10.1007/978-3-032-10745-9_19 Download citation DOI: https://doi.org/10.1007/978-3-032-10745-9_19 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-032-10744-2 Online ISBN: 978-3-032-10745-9 eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)